Updated: Crescendo rolls out iPhone app for RA Dx

Crescendo Bioscience unveiled an iPhone app as a new resource for patients. The free app, dubbed MyRA, is designed to also run on an iPad or iPod touch device and is intended help patients track their RA daily. Crescendo is known separately for Vectra DA, the company's RA blood test that measures 12 different immune endothelial, bone, cartilage and metabolic biomarkers common to the disease. The diagnostic then measures concentrations of those biomarkers from a scale of 1 to 100. Crescendo secured $28 million in new Series D financing in January 2013, money designed to help the company boost its commercialization efforts for Vectra DA. Release

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.